View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AA51 | Publication ID: Fall 2000 |
Title: Schedules of Controlled Substances: Exempt Anabolic Steroid Products | |
Abstract: The Drug Enforcement Administration (DEA) is designating six preparations as exempt anabolic steroid products. This action, as part of the ongoing implementation of the Anabolic Steroids Control Act of 1990, removes certain regulatory controls pertaining to Schedule III substances from the designated entities. | |
Agency: Department of Justice(DOJ) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Completed Actions |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 1308 | |
Legal Authority: 21 USC 811 21 USC 812 21 USC 871(b) |
Legal Deadline:
None |
|||||||||||||||||||||
Timetable:
|
Additional Information: DEA-187 | |
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: No | Federalism: No |
Included in the Regulatory Plan: No | |
Agency Contact: Frank Sapienza Chief, Drug and Chemical Evaluation Section Department of Justice Drug Enforcement Administration Office of Diversion Control, Washington, DC 20537 Phone:202 307-7183 |